Keeping up with the science: Innovation in the health and care system post Brexit
Article
Innovation in health – new treatments, technologies and processes – can help drive improvements in healthcare and ultimately health outcomes. We are on the cusp of a new wave of innovation driven by robotics, big data and therapeutic breakthroughs such as cell and gene therapy.
However, the history of innovation in the UK shows that the health and care system is often slow to adopt new technologies. The government has tried to address the causes of this problem, most recently through the Accelerated Access Review (AAR) and Life Sciences (Industrial) Strategy.
Although these initiatives offer a number of sensible policy suggestions, the reality is that they will fail to deliver on their potential without a Brexit deal that prioritises health and care; a new long-term funding settlement for health and care; and a clear plan for system reform in the NHS.
Related items
Supporting the status quo: How the taxation of wealth in the UK grows regional divides
The new government’s primary mission is to deliver economic growth, rooted in an ambition for prosperity and opportunity to be accessible across the UK.Driving 'natural' renewal: The progressive case for restoring the natural environment
Our natural environment is in crisis, and nature in this country is currently in a state of managed decline.Plugged in: Accelerating the electrification of road transport
The new government has been elected with a mandate to deliver ambitious climate action.